GlassScriptPhysician profile
Vi N Hua
NPI 1144278854
$11,577.00
in general payments reported to CMS, 2019-2025
51 companies · $2,084 in 2025
The $2,084 reported for 2025 was more than what 81% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,035 · 2020: $415 · 2021: $760 · 2022: $672 · 2023: $881 · 2024: $730 · 2025: $2,084.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,210 · Travel and Lodging: $470 · Entertainment: $15.29.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,210.21 |
| Travel and Lodging | $469.87 |
| Entertainment | $15.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,236.96 | 2019 | |
| Teleflex LLC | $1,237.74 | 2021-2025 | Urolift |
| Neotract INC. | $1,095.81 | 2019-2020 | |
| Urogen Pharma, INC. | $491.92 | 2022-2025 | Jelmyto |
| Boston Scientific Corporation | $456.09 | 2019-2023 | Lithovue, Rezum Generator |
| Antares Pharma, INC. | $333.58 | 2019-2023 | Nocdurna, Tlando, Xyosted |
| Ferring Pharmaceuticals INC. | $271.98 | 2024-2025 | Adstiladrin |
| Astellas Pharma US INC | $249.85 | 2019-2021 | |
| Telix Pharmaceuticals | $238.78 | 2025 | Illuccix, Gozellix |
| Janssen Biotech, INC. | $220.02 | 2019-2025 | Erleada |
| Procept Biorobotics Corporation | $203.49 | 2022-2025 | Aquabeam Robotic System |
| Coloplast Corp | $195.28 | 2019-2024 | |
| Blue Earth Diagnostics | $192.42 | 2019-2025 | Posluma |
| Pfizer INC. | $182.81 | 2019-2023 | |
| Abbvie INC. | $178.78 | 2019-2023 |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vi Hua listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.